Stocks OPAD Financial statements
Financial statementsOfferpad Solutions Inc. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Offerpad Solutions Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 1,076 | 1,064 | 2,070 | 3,952 | 1,314 | 919 | 568 |
| Cost of revenue | 1,001 | 976 | 1,863 | 3,770 | 1,244 | 847 | 526 |
| Gross profit | 74.4 | 87.8 | 208 | 182 | 70.2 | 72.2 | 42 |
| Research and development | 7.45 | 7.27 | 10.9 | 12.1 | 7.95 | 4.52 | 3.41 |
| Selling and marketing | 85.2 | 76.8 | 147 | 239 | 117 | 73.1 | 45.8 |
| General and administrative | 15.1 | 17.5 | 30.3 | 58.7 | 50.1 | 40.6 | 26.2 |
| Operating expenses | 108 | 102 | 188 | 310 | 175 | 118 | 75.4 |
| Operating income | -33.4 | -13.8 | 19.8 | -127 | -104 | -46 | -33.4 |
| Interest expense | 18.3 | 10 | 15.8 | 46 | 18.9 | 18.7 | 13.4 |
| Other non-operating income | -18.3 | -9.2 | -13.1 | -20.9 | -12.6 | -16.1 | -12.6 |
| Pre-tax income | -51.7 | -23 | 6.63 | -148 | -117 | -62.1 | -45.9 |
| Income tax | 0.25 | 0.16 | 0.17 | 0.36 | 0.16 | 0.03 | 0.44 |
| Net income | -52 | -23.1 | 6.46 | -149 | -117 | -62.2 | -46.4 |
| EBITDA | -33 | -13.3 | 20.3 | -126 | -104 | -45.4 | -32.4 |
| EPS, basic | -12.24 | -5.44 | 0.82 | -9.09 | -4.44 | -2.27 | -1.50 |
| EPS, diluted | -12.24 | -5.44 | 0.68 | -9.09 | -4.44 | -2.27 | -1.50 |
| Shares, basic (weighted) | 4.25 | 4.25 | 7.91 | 16.3 | 26.4 | 27.4 | 31 |
| Shares, diluted (weighted) | 4.25 | 4.25 | 9.55 | 16.3 | 26.4 | 27.4 | 31 |
Balance sheet
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 22.9 | 43.9 | 170 | 97.2 | 76 | 43 | 26.5 |
| Receivables | 2.31 | 6.17 | 2.35 | 9.94 | 3.85 | 7.94 | |
| Inventory | 171 | 1,133 | 665 | 277 | 214 | 93.8 | |
| Other current assets | 2.88 | 9.81 | 6.83 | 5.24 | 2.56 | 1.79 | |
| Total current assets | 227 | 1,343 | 814 | 372 | 294 | 132 | |
| Property, plant and equipment | 8.23 | 5.15 | 5.19 | 4.52 | 9.13 | 14.7 | |
| Lease right-of-use assets | 4.78 | 5.47 | 3.34 | 8.58 | 7.41 | ||
| Other non-current assets | 0.35 | 4.96 | 5.7 | 3.57 | 9.71 | 8.41 | |
| Total assets | 236 | 1,353 | 825 | 380 | 313 | 155 | |
| Accounts payable | 2.15 | 6.4 | 4.65 | 4.95 | 1.92 | 1.67 | |
| Accrued liabilities | 11.2 | 12.8 | 10.7 | 3.2 | 1.9 | 1.78 | |
| Total current liabilities | 190 | 1,068 | 699 | 276 | 251 | 88.8 | |
| Lease liabilities | 3.83 | 3.69 | 1.42 | 14.2 | 13.1 | ||
| Other non-current liabilities | 3.83 | 3.69 | 1.42 | 14.2 | 13.1 | ||
| Total liabilities | 195 | 1,096 | 703 | 278 | 265 | 117 | |
| Paid-in capital | 5.91 | 390 | 403 | 500 | 508 | 545 | |
| Retained earnings | -139 | -132 | -281 | -398 | -460 | -506 | |
| Treasury stock | -10.7 | 0 | |||||
| Shareholders' equity | -122 | -143 | 258 | 122 | 102 | 47.7 | 38.2 |
| Total equity | -122 | -143 | 258 | 122 | 102 | 47.7 | 38.2 |
| Total liabilities and equity | 236 | 1,353 | 825 | 380 | 313 | 155 |
Cash flow statement
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | -52 | -23.1 | 6.46 | -149 | -117 | -62.2 | -46.4 |
| Depreciation and amortization | 0.38 | 0.43 | 0.52 | 1.02 | 0.73 | 0.61 | 0.98 |
| Stock-based compensation | 1.27 | 1.36 | 3.08 | 8.31 | 7.92 | 8.08 | 2.83 |
| Deferred income tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in receivables | -1.08 | 0.94 | -3.85 | 3.82 | -7.59 | 6.09 | -4.09 |
| Change in inventory | -60.7 | 169 | -950 | 374 | 379 | 57.9 | 109 |
| Change in payables | -2.42 | 0.84 | 4.13 | -1.75 | 0.3 | -3.02 | -0.26 |
| Cash from operations | -109 | 155 | -922 | 305 | 262 | 20.8 | 66.8 |
| Capital expenditures | -1.04 | -2.86 | -13.7 | -1.07 | -0.13 | -5.41 | -1.08 |
| Cash from investing | -0.98 | -2.86 | -11.7 | -1.07 | 1.99 | -5.33 | -1.06 |
| Debt repaid | -0.06 | ||||||
| Stock issued | 0.17 | 0 | -51.2 | 0 | -0.78 | 0 | 0 |
| Share buybacks | -10.7 | ||||||
| Cash from financing | 123 | -131 | 1,077 | -358 | -324 | -21.8 | -111 |
| Net change in cash | 12.6 | 20.9 | 144 | -54.1 | -60.4 | -6.31 | -45.5 |
| Free cash flow | -110 | 152 | -936 | 304 | 262 | 15.4 | 65.7 |
| Interest paid | 20 | 14 | 21.9 | 59.7 | 24.7 | 24.5 | 16.9 |
| Income taxes paid | 0.4 | 0.3 | 0.4 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 7.4% | Gross profit / revenue. |
| Operating margin | -7.7% | Operating income / revenue. |
| EBITDA margin | -7.5% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | -9.7% | Pre-tax income / revenue. |
| Net margin | -9.8% | Net income / revenue. |
| FCF margin | 18.2% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 18.2% | Cash from operations / revenue. |
| Return on equity (ROE) | -106.8% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | -24.9% | Net income / average total assets. |
| Return on invested capital (ROIC) | -591.2% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| R&D / revenue | 0.8% | Research and development expense / revenue. |
| Stock-based pay / revenue | 0.4% | Stock-based compensation (from the cash flow statement) / revenue. |
| Capex / revenue | 0.0% | Capital expenditures / revenue. |
| D&A / revenue | 0.3% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -38.2% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | -47.6% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | -11.8% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -41.8% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | -38.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Gross profit CAGR, 5y | -13.7% | Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 220.7% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | -39.7% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | -15.5% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 326.1% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | -40.0% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | -15.4% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | -19.8% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | -32.1% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets growth, 1y | -50.6% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | -42.8% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | -8.1% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Share count change, 1y | 13.1% | Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 3y | 23.8% | Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution. |
| Share count change per year, 5y | 48.8% | Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.44x | Current assets / current liabilities. |
| Quick ratio | 0.41x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.35x | (Cash + short-term investments) / current liabilities. |
| Liabilities / assets | 76.7% | Total liabilities / total assets. |
| Interest coverage | -3.40x | Operating income / interest expense. |
| Working capital | $42.4M | Current assets - current liabilities. |
| Tangible book value | $37.3M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 2.52x | Revenue / average total assets. |
| Fixed asset turnover | 28.7x | Revenue / average property, plant and equipment. |
| Inventory turnover | 3.97x | Cost of revenue / average inventory. |
| Days inventory | 92 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 66.0x | Revenue / average receivables. |
| Days sales outstanding | 6 days | 365 x average receivables / revenue. |
| Days payables | 3 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 95 days | Days inventory + days sales outstanding - days payables. |
| Capex / operating cash flow | 0.1% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | -$8.31 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| Revenue per share | $84.36 | Revenue / diluted weighted shares. |
| FCF per share | $15.35 | Free cash flow / diluted weighted shares. |
| Operating cash flow per share | $15.36 | Cash from operations / diluted weighted shares. |
| Book value per share | $7.78 | Shareholders' equity / shares outstanding (diluted weighted shares when not reported). |
| Tangible book per share | $7.78 | Tangible book value / shares outstanding. |
| Cash per share | $6.91 | (Cash + short-term investments) / shares outstanding. |
Valuation
| Metric | Value | How it is calculated |
|---|---|---|
| Market cap | $15.8M | Share price x shares outstanding. |
| Enterprise value | -$17.3M | Market cap + total debt - cash - short-term investments. |
| P/S | 0.04x | Market cap / revenue. |
| P/B | 0.42x | Market cap / shareholders' equity. Only when equity is positive. |
| Price / tangible book | 0.42x | Market cap / tangible book value, when positive. |
| P/FCF | 0.21x | Market cap / free cash flow. Only when free cash flow is positive. |
| P/OCF | 0.21x | Market cap / cash from operations, when positive. |
| FCF yield | 465.7% | Free cash flow / market cap. |
| Earnings yield | -252.1% | Net income / market cap (the inverse of P/E). |
What was Offerpad Solutions Inc.'s revenue in fiscal 2025?
Offerpad Solutions Inc. reported revenue of $567.8M for fiscal 2025, 38.2% lower than the year before.
Was Offerpad Solutions Inc. profitable in fiscal 2025?
No. It reported a net loss of $46.4M.
How much free cash flow did Offerpad Solutions Inc. generate in fiscal 2025?
Cash from operations of $66.8M minus capital expenditures of $1.1M left free cash flow of $65.7M.